$
16. 42
+0.33
+2.051%
$
10.6B Market Cap
51.87 P/E Ratio
- Div Yield
29.36M Volume
1.01 Eps
$ 16.09
Previous Close 
Want to track AVTR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
3 Reasons Why You Should Hold Avantor (AVTR) Stock for Now
Avantor's (AVTR) strong product portfolio raises optimism about the stock.
Zacks | 2 years ago
Avantor (AVTR) Launches Solutions for Gene Therapy Harvest
Avantor, Inc. AVTR recently released two innovative products aimed at revolutionizing the gene therapy harvest process. J.T.Baker Cell Lysis Solution and J.T.Baker Endonuclease are designed to enhance efficiency, reduce environmental impact, improve operational outcomes and preserve the integrity of viral particles.
Zacks | 2 years ago
Reasons Why You Should Retain Avantor (AVTR) Stock for Now
Avantor's (AVTR) strong product portfolio raises optimism about the stock.
Zacks | 2 years ago
2026 © Marketlog. All Rights Reserved.
